- A noninferiority, randomized controlled trial of late conversion to once-daily regimen of sirolimus and extended-release tacrolimus versus mycophenolic acid and extended-release tacrolimus for kidney transplant recipients
-
Kitrungphaiboon T, Udomkarnjananan S, Kupatawintu P, Limbutara K, Iampenkhae K, Pongpirul K, Avihingsanon Y, Townamchai N
- KMID: 2535700
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S184.
- doi: 10.4285/ATW2022.F-3114
Background: Once daily regimen could improve medical adherence and quality of life. Sirolimus based regimen can reduce calcineurin inhibitor (CNI) exposure. Therefore, we conducted randomized controlled trial, comparing once daily... -
- CITED
-
- Close
- SHARE
-
- Close
